Announcement PDF ImpediMed Limited Suite 31C, 12-18 Tryon Rd Lindfield NSW 2070 Australia E: investorrelations@impedimed.com W : impedimed.com 26 October 2026 Companies Announcements Office Australian Securities Exchange Notification of Q1 FY27 Quarterly Results Investor Webinar ImpediMed Limited (ASX: IPD) advises it will release its Appendix 4C Quarterly Cash Flow Report for the period ending 30 September 2026 on Friday 30 October 2026. Investors are invited to join a webinar hosted by CEO and Managing Director, Erik Anderson and CFO and Executive Director, McGregor Grant at 9.00am AEDT on Friday 30 October 2026. To pre-register, please follow this link https://investors.impedimed.com/webinars/yVwGae-impedimed-q1- fy27-results-investor-webinar. Registered participants will receive a confirmation email and calendar notification. A question-and-answer session will follow a management presentation. Investors can ask questions live or submit questions prior to the webinar using the Q&A function found in the webinar link. Authorised for release by McGregor Grant, CFO and Executive Director ImpediMed Stay Connected Receive ASX announcements and company updates directly to your inbox, access video summaries, join our webinars and ask questions directly to the team. Sign up to the ImpediMed Investor Hub at https://investors.impedimed.com/